Wang Zicong, Li Bingyan, Zhou Haixiang, Chen Junyu, Zhu Junye, Zhou Yedi
Department of Ophthalmology, Second Xiangya Hospital, Central South University, Changsha 410011.
Hunan Clinical Research Center of Ophthalmic Diseases, Changsha 410011, China.
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2024 Dec 28;49(12):1953-1965. doi: 10.11817/j.issn.1672-7347.2024.240138.
Long noncoding RNAs (lncRNA) play important roles in the pathological processes of angiogenesis-related diseases such as cancer and diabetic retinopathy. This study aims to identify global research trends and hotspots in the field of lncRNAs in angiogenesis-related diseases and to explore future research directions.
Relevant literature published between 2012 and 2022 was retrieved from the Web of Science Core Collection (WoSCC). A total of 1 516 articles on lncRNAs and angiogenesis-related diseases were included for bibliometric analysis. CiteSpace and VOSviewer were used to analyze publication countries, institutions, journals, authors, co-cited references, and key words.
The number of publications in this field has shown a steadily increasing trend from 2012 to 2022, peaking in 2021. China has the highest number of publications, while the United States ranked highest in centrality. Nanjing Medical University was the most prolific institution. Liu Y was the most productive author, while Wang Y ranked first in co-citation frequency. was the most frequently cited journal. The latest terms of burst key words were vascular remodeling, dysfunction, heart, target, suppress, and pulmonary arterial hypertension.
From 2012 to 2022, research on lncRNAs in angiogenesis-related diseases has grown significantly. China leads in publication volume, while the United States holds the most academic influence. Emerging research hotspots such as vascular remodeling and dysfunction point to key directions for future research.
长链非编码RNA(lncRNA)在癌症和糖尿病视网膜病变等血管生成相关疾病的病理过程中发挥着重要作用。本研究旨在确定血管生成相关疾病中lncRNA领域的全球研究趋势和热点,并探索未来的研究方向。
从科学网核心合集(WoSCC)中检索2012年至2022年发表的相关文献。共纳入1516篇关于lncRNA与血管生成相关疾病的文章进行文献计量分析。使用CiteSpace和VOSviewer分析发表国家、机构、期刊、作者、共被引参考文献和关键词。
该领域的出版物数量从2012年到2022年呈稳步增长趋势,在2021年达到峰值。中国的出版物数量最多,而美国在中心性方面排名最高。南京医科大学是发文量最多的机构。刘Y是发文量最多的作者,而王Y在共被引频次方面排名第一。 是被引频次最高的期刊。突发关键词的最新术语是血管重塑、功能障碍、心脏、靶点、抑制和肺动脉高压。
2012年至2022年期间,血管生成相关疾病中lncRNA的研究显著增加。中国在发文量方面领先,而美国具有最大的学术影响力。血管重塑和功能障碍等新兴研究热点为未来研究指明了关键方向。